| Entry |
|
|---|
| Name |
Rasagiline mesylate (USAN);
Rasagiline mesilate (JAN);
Azilect (TN)
|
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C12H13N. CH4SO3
|
|---|
| Exact mass |
267.0929
|
|---|
| Mol weight |
267.344
|
|---|
| Structure |
     |
|---|
| Class |
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01512 Monoamine oxidase B inhibitor
DG01967 Antiparkinson agent
|
|---|
| Remark |
Therapeutic category: ATC code: Chemical structure group: Product in DG00865: D02562<US> |
|---|
| Efficacy |
Antiparkinsonian, Monoamine oxidase B (MAO-B) inhibitor |
|---|
| Target |
|
|---|
| Pathway |
| Serotonergic synapse | | Dopaminergic synapse |
|
|---|
| Interaction |
|
|---|
| Structure map |
| Antidepressants | | Antiparkinsonian agents | | Catecholamine transferase inhibitors |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BD Monoamine oxidase B inhibitors
N04BD02 Rasagiline
D02562 Rasagiline mesylate (USAN)
USP drug classification [BR:br08302]
Antiparkinson Agents
Monoamine Oxidase B (MAO-B) Inhibitors
Rasagiline
D02562 Rasagiline mesylate (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
116 Antiparkinsonian agents
1169 Others
D02562 Rasagiline mesylate (USAN); Rasagiline mesilate (JAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases
monoamine oxidase B (MAO-B)
Rasagiline
D02562 Rasagiline mesylate (USAN)
Drug classes of therapeutic agents [br08360.html]
Neurological agents
D02562
New drug approvals in the USA [br08319.html]
New Molecular Entity and New Therapeutic Biological Product Approvals
D02562
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D02562
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02562
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02562
 |
|---|
| Other DBs |
CAS: 161735-79-1 PubChem: ChEMBL: DrugBank: LigandBox: |
|---|
| KCF data |
ATOM 18
1 C8y C 19.8358 -20.6271
2 C8y C 19.8358 -19.2233
3 C8x C 18.6201 -18.5214
4 C8x C 17.4042 -19.2233
5 C8x C 17.4042 -20.6271
6 C8x C 18.6201 -21.3291
7 C1y C 21.1709 -21.0609
8 C1x C 21.9961 -19.9252
9 C1x C 21.1709 -18.7895
10 N1b N 21.1694 -22.4521
11 C1b C 22.3845 -23.1554
12 C3b C 23.5851 -22.4638
13 C3a C 24.7493 -21.7502
14 O1d O 30.5752 -19.7146
15 S4a S 30.5752 -21.1185
16 C1a C 29.1714 -21.1185
17 O1d O 31.9791 -21.1185
18 O1d O 30.5752 -22.5223
BOND 18
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 7 8 1
9 8 9 1
10 2 9 1
11 7 10 1 #Up
12 10 11 1
13 11 12 1
14 12 13 3
15 14 15 2
16 15 16 1
17 15 17 1
18 15 18 2
|
|---|
